- Zurn Elkay Water Solutions Corporation has already reported its second quarter 2026 results, with sales of US$491.0 million and net income of US$113.3 million, up from US$444.5 million and US$50.5 million a year earlier.
- The company’s earnings per share from continuing operations more than doubled year on year, while it also affirmed a quarterly dividend of US$0.11 per share payable in early September 2026.
- With earnings per share from continuing operations rising to US$0.67 diluted in the quarter, we’ll assess how this shapes Zurn Elkay’s investment narrative.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
Zurn Elkay Water Solutions Investment Narrative Recap
Zurn Elkay’s story still centers on long term demand for safer, better managed water in non residential buildings, especially schools and hospitals. The latest Q2 result, with higher sales and earnings per share, supports that narrative but does not fully resolve shorter term questions about how much growth is driven by underlying demand versus prior ordering ahead of price increases, which remains a key near term risk.
The reaffirmed quarterly dividend of US$0.11 per share, payable in early September 2026, is the most relevant recent announcement here, as it sits alongside higher earnings and highlights how management is allocating cash at a time when tariff exposure and raw material costs could still pressure margins if conditions turn less favorable.
Yet behind the strong earnings print, investors should be aware of how reliant Zurn Elkay remains on funding trends in healthcare and education...
Read the full narrative on Zurn Elkay Water Solutions (it's free!)
Zurn Elkay Water Solutions' valuation narrative projects $2.1 billion revenue and $307.8 million earnings by 2029.
Uncover how Zurn Elkay Water Solutions' forecasts yield a $56.22 fair value, a 14% upside to its current price.
Exploring Other Perspectives
Two members of the Simply Wall St Community currently see Zurn Elkay’s fair value between US$52.20 and US$56.20, highlighting how personal forecasts can cluster. You should weigh those views against the risk that some recent growth may have been pulled forward by customers ordering ahead of price increases, and consider how different demand scenarios could affect your own expectations.
Explore 2 other fair value estimates on Zurn Elkay Water Solutions - why the stock might be worth as much as 14% more than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Zurn Elkay Water Solutions research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free Zurn Elkay Water Solutions research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zurn Elkay Water Solutions' overall financial health at a glance.
Looking For Alternative Opportunities?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com